Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Russia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
By
Russia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
ByPharmaceutical Technology lists five of the most popular tweets on infectious diseases in May 2022 based on data from GlobalData’…
The metaverse will make digital media experiences more immersive, inclusive, and accessible than today. However, it will raise social concerns…
CMOs have been increasingly adopting the use of continuous manufacturing for biologics production following FDA approval.
ByGaming and social media companies are at the vanguard of metaverse development, but enterprises will lead the charge in the…
The metaverse brings together a range of next-generation technologies from cloud computing to artificial intelligence (AI), blockchain, cryptocurrencies, cybersecurity, the…
Ashvattha Therapeutics’ D-4517.2 stands out among anti-VEGF treatments in that it can be self-administered using an autoinjector.
ByFurther trials for pediatric and heart failure patients are currently ongoing.
ByThank you for subscribing to Pharmaceutical Technology